**Question:** Amyl nitrate inhalation test is used to detect

A. pulmonary hypertension
B. chronic obstructive pulmonary disease (COPD)
C. asthma
D. bronchial asthma

**Core Concept:**

The amyl nitrate inhalation test is a diagnostic procedure used in the evaluation of suspected pulmonary hypertension. It is based on the principle that inhaled nitrates like amyl nitrate cause vasodilation of pulmonary vasculature and increase pulmonary blood flow, which is more pronounced in patients with pulmonary hypertension compared to those without the condition.

**Why the Correct Answer is Right:**

The test is performed by inhaling amyl nitrate, a rapid-acting nitrate vasodilator. In healthy individuals with normal pulmonary vascular resistance, the vasodilation following nitrate inhalation would be minimal. However, in patients with pulmonary hypertension, the vasodilatory response is exaggerated due to increased pulmonary vascular resistance and endothelin production. This exaggerated response helps in differentiating pulmonary hypertension from other causes of increased pulmonary vascular resistance, such as chronic obstructive pulmonary disease (COPD) and asthma.

**Why Each Wrong Option is Incorrect:**

A. Pulmonary hypertension is a correct answer but the test is specifically designed to differentiate it from other causes of increased pulmonary vascular resistance, not to confirm its presence.

B. Chronic obstructive pulmonary disease (COPD) is incorrect because the test is not used to diagnose COPD but to differentiate pulmonary hypertension from COPD. In COPD, the vasodilatory response to nitrates may be reduced due to decreased nitric oxide production and impaired endothelial function.

C. Asthma is incorrect because the test is not used to diagnose asthma but to differentiate pulmonary hypertension from asthma. In asthma, nitrate-induced vasodilation is not exaggerated, but rather, it can be reduced due to decreased nitric oxide production and impaired endothelial function, similar to COPD.

D. Bronchial asthma is incorrect for the same reasons as asthma (option C). The test is not used to diagnose asthma but to differentiate pulmonary hypertension. In asthma, nitrate-induced vasodilation is not exaggerated, but rather, it can be reduced due to decreased nitric oxide production and impaired endothelial function, similar to COPD.

**Clinical Pearl:**

The amyl nitrate inhalation test aids in differentiating pulmonary hypertension from other causes of increased pulmonary vascular resistance (such as COPD and asthma), by assessing the exaggerated vasodilatory response to nitrates in pulmonary hypertension. In asthma and COPD, nitrate-induced vasodilation is reduced due to decreased nitric oxide production and impaired endothelial function.